No abstract available
Keywords:
antiviral; host; infection; restriction; virus.
Grants and funding
The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. JJ-G received support from the Grant RYC2021-031227-I funded by the MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR, the Grant Proyecto19 funded by the Universidad de Málaga Plan Propio (Ayuda G), the Grant CNS2023-143738 funded by the MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR, the grant PID2022-136217OA-I00 funded by the MCIN/AEI/10.13039/501100011033/FEDER, UE and the grant FORT23/00013 funded by the Programa fortalece del Ministerio de Ciencia e Innovación and the Instituto de Salud Carlos III (ISCIII). LM-A received support from the Ministry of Science, Innovation and Universities of Spain through grant PID2022-136725OB-I00/AEI/10.13039/501100011033 awarded to LM-A. An institutional grant of the Fundacion Ramon Areces (Madrid, Spain) to the CBMSO is also acknowledged. The CBMSO has been certified since 2023 as Severo Ochoa Center of Excellence by AEI/MCI/10.13039/501100011033. LM-A is member of the Global Virus Network. GB received support from the Grant RYC2021-032674-I funded by the MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR.